2008
DOI: 10.1016/j.jaad.2007.03.015
|View full text |Cite
|
Sign up to set email alerts
|

Interstitial granulomatous dermatitis in a child with chronic uveitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
22
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(24 citation statements)
references
References 8 publications
2
22
0
Order By: Relevance
“…They have been described in the setting of RA, 14 juvenile idiopathic arthritis, 15 SLE, 16 ulcerative colitis, 17 vasculitis, 18 chronic uveitis 19 and lymphoproliferative diseases, 20 conditions believed to induce maintained production of immune reactants.…”
Section: Discussionmentioning
confidence: 99%
“…They have been described in the setting of RA, 14 juvenile idiopathic arthritis, 15 SLE, 16 ulcerative colitis, 17 vasculitis, 18 chronic uveitis 19 and lymphoproliferative diseases, 20 conditions believed to induce maintained production of immune reactants.…”
Section: Discussionmentioning
confidence: 99%
“…42 Similar to PNGD, there is a 3:1 female to male predominance, 38 again likely owing to the association with underlying autoimmune diseases. The initial description of IGD was that of linear subcutaneous cords or bands on the proximal trunk, 32 although over time the clinical morphologic spectrum has expanded and many feel that other presentations are in fact more common with cords reported in less than 10% of cases.…”
Section: Clinical and Histologic Presentationmentioning
confidence: 99%
“…As such, reported treatments include aggressive systemic agents geared toward controlling the IGD-associated systemic disease, which may also clear the IGD (systemic steroids, 38 etanercept, 38,47 methotrexate, 36,38 cyclosporine, 46 intravenous immunoglobulin, 71 tocilizumab, 72 and ustekinumab 50 ). There are reports of improvement with topical steroids, 38,42,46 nonsteroidal antiinflammatory drugs, 46,73 systemic corticosteroids, 43,46 dapsone, and hydroxychloroquine. 46 Infliximab was used for a recalcitrant case.…”
Section: Evaluation and Managementmentioning
confidence: 99%
“…The associated conditions, for example, SLE or rheumatoid arthritis, could have a significant role in influencing the choice of agents. Treatment options include non-steroidal anti-inflammatory drugs,14 topical steroids,13 15 systemic steroids6 16 17 or any combination of these agents 8 18. Other available options for more resistant cases include methotrexate,19 anti-TNF agents,20 21 toclizumab,22 ustekinumab23 and IVIG 24.…”
Section: Discussionmentioning
confidence: 99%